Regenerative Medicine: The Next Big Wave in Orthopedics?
Standardization, Registry Data, and Collaboration Needed
TOBI Hosts 9th Annual PRP & Regenerative Medicine Symposium: June 7-9, 2018
The field of orthopedic medicine is being revolutionized by regenerative medicine, using the body’s own cells as a means of repair. High profile athletes began using the treatments, and, after seeing major names in the media, patients ignited the field. The Orthobiologic Institute (TOBI) has emerged as a leading meeting that brings together top physicians & field experts from around the world to address the need for standardization and collaboration of research in this rapidly expanding field of medicine.
According to Research Nester, the market for Stem Cell Regenerative Medicine will reach over $50 Billion USDby 2021. Major institutions, including Harvard, Mayo Clinic, Stanford, and Emory, feature musculoskeletal regenerative clinics. Clinical use and public demand are outpacing research in the field. Regenerative medicine treatments can, in some cases, eliminate the need for surgery and/or prescription painkillers for many.
With a surge in scientific potential and public interest, the US Food and Drug Administration (FDA) and American Academy of Orthopedic Surgery (AAOS) have addressed the need for regulatory guidelines and inclusion of national registries to track patient data. The FDA recently released a comprehensive regenerative medicine policy framework for the development and oversight of regenerative medicine products and novel cellular therapies to protect patients from potentially unsafe products.
The AAOS issued a position statement on emerging biologic therapies emphasizing patient education, informed consent and encouraging patient registries to monitor safety and efficacy. In 2017, TOBI launched its official registry to do just that – the Regenerative Orthobiogics Registry (ROR), founded by Dr. Steven Sampson, founder of TOBI, and Dr. Gregory Lutz, Physiatrist-in-Chief at the Hospital for Special Surgery.
On June 7-9 2018, The Orthobiologic Institute (TOBI) will host its 9th PRP & Regenerative Medicine Symposium at Wynn Las Vegas featuring leading experts representing over 40 countries, with a goal of sharing research, as well as promoting standardization and best practice. Faculty from Mayo Clinic, Harvard, Stanford, Wake Forest, Case Western, Emory, and more gather year after year at this meeting. TOBI is revolutionizing the field of regenerative medicine to bring biologics into standard care for orthopedic injuries.